|
Information For:
|
Compendial NoticeProspective Harmonization
In July 2008, USP and the European Pharmacopoeia (PhEur) initiated a Prospective Harmonization pilot study for the joint development of four drug substance monographs and their associated reference materials. Two of the monographs, Montelukast Sodium and Rizatriptan Benzoate, are ready for public comment. In order to coordinate the publication of the monographs proposals with PhEur's Pharmeuropa 21.4 October 2009, USP is presenting the proposals on the USP Web site. The monographs will also appear in Pharmacopeial Forum 36(1) [Jan-Feb 2010]. Comments are due April 15, 2010. Should you have questions, please contact Karen Russo, Ph.D. (kar@usp.org or 301-816-8379). What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||